pISSN 2234-3806eISSN 2234-3814
Table. 2.
Comparison of laboratory findings between patients with KD at the time of diagnosis and at 2, 14, and 56 days after IVIG treatment and patients with other acute febrile illnesses
| Laboratory Findings | Patients with KD | Patients with other acute febrile illnesses | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| At the time of diagnosis | 2 days after treatment | 14 days after treatment | 56 days after treatment | |||||||
| N | Value | N | Value | N | Value | N | Value | N | Value | |
| CRP (mg/L), median (range) | 77 | 84 (8–232) | 77 | 22 (2–164) | 74 | 2 (0–31) | 65 | 0 (0–1) | 32 | 45 (5–118) |
| ESR (mm/hr), (mean ± SD) | 48 | 74 ± 27 | 61 | 78 ± 30 | 74 | 44 ± 27 | 65 | 11 ± 12 | 10 | 30 ± 20 |
| NT-proBNP (ng/L), median (range) | 75 | 788 (56–3,500) | 76 | 569 (14–2,3367) | 72 | 91 (16–648) | 7 | 133 (22–348) | 20 | 204 (21–2,069) |
| Ferritin (µg/L), median (range) | 77 | 188.8 (25.5–750.5 | 71 | 159.5 (4.8–483.0) | 68 | 78.2 (12.4–271.1) | 14 | 26.1 (11.0–133.5) | 32 | 106.8 (11.1–632.2) |
Abbreviations: KD, Kawasaki disease; IVIG, intravenous immunoglobulin; CRP, C-reactive protein, ESR, erythrocyte sedimentation rate; NT-proBNP, N-terminal pro-brain natriuretic peptide; SD, standard deviation.
Ann Lab Med 2021;41:318~322 https://doi.org/10.3343/alm.2021.41.3.318
© Ann Lab Med